NO942686D0 - Use of 3-arylindole and 3-arylindazole derivatives in the treatment of psychoses - Google Patents
Use of 3-arylindole and 3-arylindazole derivatives in the treatment of psychosesInfo
- Publication number
- NO942686D0 NO942686D0 NO942686A NO942686A NO942686D0 NO 942686 D0 NO942686 D0 NO 942686D0 NO 942686 A NO942686 A NO 942686A NO 942686 A NO942686 A NO 942686A NO 942686 D0 NO942686 D0 NO 942686D0
- Authority
- NO
- Norway
- Prior art keywords
- arylindole
- psychoses
- treatment
- arylindazole
- derivatives
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK9284A DK8492D0 (en) | 1992-01-23 | 1992-01-23 | TREATMENT OF PSYCHOSIS |
| PCT/DK1993/000021 WO1993014758A1 (en) | 1992-01-23 | 1993-01-22 | Use of 3-arylindole and 3-arylindazole derivatives for the treatment of psychoses |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO942686D0 true NO942686D0 (en) | 1994-07-18 |
| NO942686L NO942686L (en) | 1994-07-18 |
Family
ID=8089556
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO942686A NO942686L (en) | 1992-01-23 | 1994-07-18 | Use of 3-arylindole and 3-arylindazole derivatives in the treatment of psychoses |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0621781A1 (en) |
| JP (1) | JPH07503240A (en) |
| AU (1) | AU670063B2 (en) |
| CA (1) | CA2128699A1 (en) |
| CZ (1) | CZ176494A3 (en) |
| DK (1) | DK8492D0 (en) |
| NO (1) | NO942686L (en) |
| RU (1) | RU94035658A (en) |
| SK (1) | SK86394A3 (en) |
| WO (1) | WO1993014758A1 (en) |
| ZA (1) | ZA93491B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK206591D0 (en) * | 1991-12-23 | 1991-12-23 | Lundbeck & Co As H | TREATMENT OF PSYCHOSIS |
| EP0990653B1 (en) * | 1997-05-30 | 2004-09-15 | Banyu Pharmaceutical Co., Ltd. | 2-oxoimidazole derivatives |
| US7781478B2 (en) | 2004-07-14 | 2010-08-24 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE58370B1 (en) * | 1985-04-10 | 1993-09-08 | Lundbeck & Co As H | Indole derivatives |
| GB8908085D0 (en) * | 1989-04-11 | 1989-05-24 | Lundbeck & Co As H | New therapeutic use |
| DK181190D0 (en) * | 1990-07-30 | 1990-07-30 | Lundbeck & Co As H | 3-ARYL-INDOL OR 3-ARYL-INDAZOL DERIVATIVES |
-
1992
- 1992-01-23 DK DK9284A patent/DK8492D0/en not_active Application Discontinuation
-
1993
- 1993-01-22 AU AU34494/93A patent/AU670063B2/en not_active Ceased
- 1993-01-22 WO PCT/DK1993/000021 patent/WO1993014758A1/en not_active Application Discontinuation
- 1993-01-22 SK SK863-94A patent/SK86394A3/en unknown
- 1993-01-22 ZA ZA93491A patent/ZA93491B/en unknown
- 1993-01-22 CZ CZ941764A patent/CZ176494A3/en unknown
- 1993-01-22 EP EP93903188A patent/EP0621781A1/en not_active Withdrawn
- 1993-01-22 JP JP5512865A patent/JPH07503240A/en active Pending
- 1993-01-22 CA CA002128699A patent/CA2128699A1/en not_active Abandoned
-
1994
- 1994-07-18 NO NO942686A patent/NO942686L/en unknown
- 1994-07-22 RU RU94035658/14A patent/RU94035658A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK8492D0 (en) | 1992-01-23 |
| ZA93491B (en) | 1993-08-23 |
| EP0621781A1 (en) | 1994-11-02 |
| CA2128699A1 (en) | 1993-08-05 |
| JPH07503240A (en) | 1995-04-06 |
| WO1993014758A1 (en) | 1993-08-05 |
| AU3449493A (en) | 1993-09-01 |
| AU670063B2 (en) | 1996-07-04 |
| RU94035658A (en) | 1996-06-20 |
| CZ176494A3 (en) | 1995-04-12 |
| NO942686L (en) | 1994-07-18 |
| SK86394A3 (en) | 1995-04-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI950587A (en) | Methods useful in the prevention and treatment of endotoxin poisoning | |
| BR9406209A (en) | Heterocyclic derivatives in the treatment of ischemia and related diseases | |
| NO970373L (en) | Benzoxazoles and pyridine derivatives useful in the treatment of type II diabetes | |
| AU3959193A (en) | Heterocyclic compounds and their use in the treatment of type II-diabetes | |
| KR100321237B1 (en) | Laminate and use of the same | |
| GB9323044D0 (en) | In or relating to the treatment of effluents | |
| DE69403862T2 (en) | Surface-modified application unit and process | |
| NO972426D0 (en) | Method for the use of triarylethylene derivatives in the treatment and prevention of osteoporosis | |
| FI955786A0 (en) | Use of natural products and similar synthetic compounds in the treatment of cardiovascular diseases | |
| SG46724A1 (en) | Use of granisetron for the treatment of post operative nausea and vomittung | |
| AU4787593A (en) | Heterocyclic derivatives useful in the treatment of cardiovascular diseases | |
| NO934311L (en) | alpha, omega-diarylalkane derivatives, their preparation and use in the treatment of circulatory disorders and psychoses | |
| DE59306085D1 (en) | HAIR AND BODY TREATMENT | |
| NO942686D0 (en) | Use of 3-arylindole and 3-arylindazole derivatives in the treatment of psychoses | |
| SG46705A1 (en) | Solutions of polyimide-forming substances and their use | |
| NO940190D0 (en) | Use of x-ketoglutarate | |
| FI964809A0 (en) | In the case of use of the processing unit | |
| NO920171D0 (en) | DEVICE AND PROCEDURES IN THE FITTING OF BEARING PLATES BOTTLES | |
| NO962503D0 (en) | Use of penoxyphylline in the treatment of multiple sclerosis | |
| NO922340D0 (en) | FR, AND PROCEDURE FOR AA OPTIMIZE THE EFFECT OF PIGMENTS IN FOR SALMONIDES | |
| NO931399D0 (en) | USE OF NATURSTEIN | |
| NO952194D0 (en) | Spirofuranone derivatives and their use in the treatment of neurodegenerative diseases | |
| AU2705495A (en) | Use of rooperol and hypoxoside and their derivatives in the treatment of inflammatory | |
| FI934950A0 (en) | The use of furancarboxamides in the shielding material | |
| NO986053L (en) | Anticonvulsant derivatives for use in the treatment of psoriasis |